<DOC>
	<DOCNO>NCT00731198</DOCNO>
	<brief_summary>The aim present study evaluate use drotaverine hydrochloride versus hyoscine-N-butylbromide reduce duodenal motility diagnostic therapeutic ERCP .</brief_summary>
	<brief_title>Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography ( ERCP )</brief_title>
	<detailed_description>ERCP important endoscopic technique diagnosis treatment pancreatic biliary disease . Duodenal peristalsis make cannulation papilla necessary therapeutic procedure difficult . Intravenous hyoscine-N-butylbromide often use ERCP inhibit duodenal motility enhance cannulation China . However , pharmaceutical agent occasionally associate serious complication cardiovascular event anaphylactic shock . Hyoscine-N-butylbromide may also affect ocular , urinary , salivary system . Drotaverine hydrochloride analogue papaverine smooth muscle relaxant property . It non-anticholinergic antispasmodic , selectively inhibits phosphodiesterase IV accompany mild calcium channel-blocking effect . Adverse effect drotaverine hydrochloride , hypotension , vertigo , nausea , palpitation , mostly mild . It suppose intravenous drotaverine hydrochloride might feasible antimotility alternative intravenous hyoscine-N-butylbromide ERCP . But clear evidence recommend use drotaverine hydrochloride antispasmodic ERCP . The aim present study evaluate use drotaverine hydrochloride versus hyoscine-N-butylbromide reduce duodenal motility diagnostic therapeutic ERCP . The effect drotaverine hydrochloride facilitative cannulation adverse effect also compare hyoscine-N-butylbromide .</detailed_description>
	<mesh_term>Pancreatic Diseases</mesh_term>
	<mesh_term>Bile Duct Diseases</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<mesh_term>Drotaverin</mesh_term>
	<mesh_term>Papaverine</mesh_term>
	<criteria>All patient undergo ERCP age 18 year Patient Billroth II gastrectomy Known previous sphincterotomy Active acute pancreatitis ERCP Ongoing acute cholangitis ERCP Hypotension ( systolic blood pressure &lt; 100 mmHg ) Seconddegree thirddegree atrioventricular block Heart failure Glaucoma Obstructive uropathy Impaired renal function ( serum creatinine &gt; 133Î¼mol/L ) Pregnant breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>ERCP</keyword>
	<keyword>Drotaverine hydrochloride</keyword>
	<keyword>Hyoscine-N-butylbromide</keyword>
</DOC>